DR. GHALEB H DAOUK, MD
Medical Practice at Longwood Ave, Boston, MA
License number
Massachusetts 72324
Category
Medical Practice
Type
Pediatric Nephrology
Address
Address
2
300 Longwood Ave, Boston, MA 02115
4 Ross Rd, Belmont, MA 02478
4 Ross Rd, Belmont, MA 02478
Phone
(617) 355-6129
(617) 730-0569 (Fax)
(617) 489-0928
(617) 489-0927 (Fax)
(617) 730-0569 (Fax)
(617) 489-0928
(617) 489-0927 (Fax)
Personal information
See more information about GHALEB H DAOUK at radaris.comName
Address
Phone
4 Ross Rd, Belmont, MA 02478
Belmont, MA
910 Beacon St, Boston, MA 02215
4 Ross Rd, Belmont, MA 02478
4 Ross Rd, Belmont, MA 02478
Professional information
Pediatric Nephrologist At Children's Hospital In Boston
Position:
Pediatric Nephrologist at Children's Hospital in Boston
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Children's Hospital in Boston
since May 2005
-
Pediatric Nephrologist
Boston Children's Hospital
2005 - 2012
-
Director extramural clinical service, nephrology
Massachusetts General Hospital
- Boston, MA Jul 1994 - May 2005
-
Clinical Director, Pediatric Nephrology
Education:
Massachusetts Institute of Technology - Sloan School of Management 1990 - 1991
SM, Management of Technology American University of Beirut 1979 - 1983
MD, Medicine Syracuse University 1977 - 1979
BS Magna cum laude, Biology/chemistry International college, Beirut Lebanon 1968 - 1974
Baccalaureat Sciences Experimentales
SM, Management of Technology American University of Beirut 1979 - 1983
MD, Medicine Syracuse University 1977 - 1979
BS Magna cum laude, Biology/chemistry International college, Beirut Lebanon 1968 - 1974
Baccalaureat Sciences Experimentales
Honor & Awards:
Phi Beta Kappa, Outstanding Alumni Award (Syracuse U.)
Assistant Professor At Harvard Medical School
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Ghaleb Hasan Daouk, Boston MA
Specialties:
Pediatrics, Pediatric Nephrology
Work:
Children's Hospital
300 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
Education:
American University Of Beirut (1984)
Dr. Ghaleb H Daouk, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
300 Longwood Ave, Boston 02115
(617) 355-6129 (Phone)
(617) 355-6129 (Phone)
Certifications:
Pediatrics, 2006
Awards:
Healthgrades Honor Roll
Languages:
English, Armenian, Creole
Education:
Medical School
American University Of Beirut, Faculty Of Medicine
Graduated: 1984
Mass Gen Hospital
American University Of Beirut, Faculty Of Medicine
Graduated: 1984
Mass Gen Hospital
Ghaleb H Daouk, Boston MA
Specialties:
Pediatrician
Address:
300 Longwood Ave, Boston, MA 02115
Education:
American University of Beirut, Faculty of Medicine - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Pediatric Nephrology (Pediatrics)
Massachusetts General Hospital - Fellowship - Pediatric Nephrology (Pediatrics)
Use Of Creatine Or Creatine Analogs For The Treatment Of Diseases Of The Nervous System
US Patent:
7285573, Oct 23, 2007
Filed:
Nov 21, 2003
Appl. No.:
10/718846
Inventors:
Ghaleb Daouk - Belmont MA, US
M. Flint Beal - New York NY, US
M. Flint Beal - New York NY, US
Assignee:
Avicena Group, Inc. - Palo Alto CA
The General Hospital Corp. - Boston MA
The General Hospital Corp. - Boston MA
International Classification:
A01N 37/52
US Classification:
514565, 514631
Abstract:
The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases. The creatine compounds which can be used in the present method include (1) creatine, creatine phosphate and analogs of these compounds which can act as substrates or substrate analogs for creatine kinase; (2) bisubstrate inhibitors of creatine kinase comprising covalently linked structural analogs of adenosine triphosphate (ATP) and creatine; (3) creatine analogs which can act as reversible or irreversible inhibitors of creatine kinase; and (4) N-phosphorocreatine analogs bearing non-transferable moieties which mimic the N-phosphoryl group.
Use Of Creatine Or Creatine Analogs For The Treatment Of Diseases Of The Nervous Sysyem
US Patent:
2002016, Oct 31, 2002
Filed:
May 7, 1997
Appl. No.:
08/853174
Inventors:
GHALEB DAOUK - BELMONT MA, US
M. FLINT BEAL - BOSTON MA, US
M. FLINT BEAL - BOSTON MA, US
International Classification:
A61K031/198, A61K031/505, A61K031/44
US Classification:
514/565000, 514/275000, 514/385000, 514/386000, 514/356000, 514/553000, 514/501000, 514/563000, 514/564000, 514/575000, 514/631000, 514/636000, 514/646000
Abstract:
The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases. The Creatine compounds which can be used in the present method include (1) creatine, creatine phosphate and analogs of these compounds which can act as substrates or substrate analogs for creatine kinase; (2) bisubstrate inhibitors of creatine kinase comprising covalently linked structural analogs of adenosine triphosphate (ATP) and creatine; (3) creatine analogs which can act as reversible or irreversible inhibitors of creatine kinase; and (4) N-phosphorocreatine analogs bearing non-transferable moieties which mimic the N-phosphoryl group.
Use Of Creatine Or Creatine Analogs For The Treatment Of Diseases Of The Nervous System
US Patent:
2004010, May 27, 2004
Filed:
Nov 21, 2003
Appl. No.:
10/718765
Inventors:
Ghaleb Daouk - Belmont MA, US
M. Beal - New York NY, US
M. Beal - New York NY, US
International Classification:
A61K031/66, A61K031/198
US Classification:
514/114000, 514/562000, 514/565000
Abstract:
The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases. The creatine compounds which can be used in the present method include (1) creatine, creatine phosphate and analogs of these compounds which can act as substrates or substrate analogs for creatine kinase; (2) bisubstrate inhibitors of creatine kinase comprising covalently linked structural analogs of adenosine triphosphate (ATP) and creatine; (3) creatine analogs which can act as reversible or irreversible inhibitors of creatine kinase; and (4) N-phosphorocreatine analogs bearing non-transferable moieties which mimic the N-phosphoryl group.